Diaceutics PLC (DXRX) — Working Capital to Net Assets Ratio
Diaceutics PLC (DXRX) has a Working Capital to Net Assets ratio of 49.1% as of June 2025. Working capital of GBX18.28 Million (current assets of GBX24.46 Million minus current liabilities of GBX6.18 Million) is measured against net assets of GBX37.24 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See how leveraged is Diaceutics PLC's balance sheet to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Diaceutics PLC Working Capital to Net Assets (2015–2024)
This chart shows how Diaceutics PLC's Working Capital to Net Assets ratio has evolved across 10 annual periods from 2015 to 2024. As of June 2025, the ratio stands at 49.1%, reflecting working capital of GBX18.28 Million against net assets of GBX37.24 Million GBX. Check tangible equity quality of Diaceutics PLC to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Diaceutics PLC (2015–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Diaceutics PLC from 2015 to 2024, covering 10 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see DXRX market cap overview.
| Year | WC/NA Ratio | Working Capital (GBX) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 54.6% | GBX21.76 Million | GBX39.86 Million | GBX29.53 Million | GBX7.76 Million | ▼ -3.4 pp |
| 2023 | 58.0% | GBX23.66 Million | GBX40.79 Million | GBX28.04 Million | GBX4.38 Million | ▼ -5.8 pp |
| 2022 | 63.8% | GBX27.14 Million | GBX42.51 Million | GBX30.90 Million | GBX3.75 Million | ▼ -3.6 pp |
| 2021 | 67.5% | GBX27.43 Million | GBX40.65 Million | GBX30.06 Million | GBX2.63 Million | ▼ -8.8 pp |
| 2020 | 76.3% | GBX30.70 Million | GBX40.24 Million | GBX33.62 Million | GBX2.92 Million | ▼ -4.1 pp |
| 2019 | 80.4% | GBX16.18 Million | GBX20.13 Million | GBX18.42 Million | GBX2.24 Million | ▼ -15.8 pp |
| 2018 | 96.2% | GBX2.53 Million | GBX2.63 Million | GBX6.46 Million | GBX3.93 Million | ▼ -51.1 pp |
| 2017 | 147.2% | GBX2.76 Million | GBX1.88 Million | GBX4.83 Million | GBX2.06 Million | ▼ -31.5 pp |
| 2016 | 178.7% | GBX1.81 Million | GBX1.01 Million | GBX3.23 Million | GBX1.42 Million | ▼ -59.1 pp |
| 2015 | 237.8% | GBX396.50K | GBX166.71K | GBX1.32 Million | GBX927.33K | — |